Abstract
Presentation Description :
The obvious method of drug delivery to ocular surface malignancy is via sole, neoadjuvant, or adjuvant treatment with topical drops. Other methods such as intralesional, subconjunctival, systemic, or iontophoresis delivery can be considered.
This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.